CI
Celcuity Inc.
SEC filingBiotechnology · Minneapolis, MN
Amount raised$130Msold at filing
Total offering$352.7M$222.7M still open
Investors in the raise2count reported to the SEC
FiledSep 23, 2025first sale Apr 8, 2021
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Vicky G. HahneExecutive Officer
David F. DalveyDirector
Richard E. BullerDirector
Polly A. MurphyDirector
Richard J. NigonDirector
Leo T. FurchtDirector
Lance G. LaingExecutive Officer, Director
Brian F. SullivanExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.